This map shows the geographic impact of C Théodore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Théodore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Théodore more than expected).
This network shows the impact of papers produced by C Théodore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Théodore. The network helps show where C Théodore may publish in the future.
Co-authorship network of co-authors of C Théodore
This figure shows the co-authorship network connecting the top 25 collaborators of C Théodore.
A scholar is included among the top collaborators of C Théodore based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with C Théodore. C Théodore is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Escudier, Bernard, Françoise Farace, C Théodore, et al.. (1995). [Treatment of metastatic kidney neoplasms with a new interleukin 2 protocol: The experience of the Gustave-Roussy Institute].. PubMed. 82(4). 296–302.1 indexed citations
8.
Farhat, F., et al.. (1994). [Liposarcoma of the spermatic cord: apropos of a case with review of the literature].. PubMed. 81(3). 223–5.1 indexed citations
9.
Ribrag, Vincent, Droz Jp, Carole Bouleuc, et al.. (1990). [Salvage chemotherapy of non-seminomatous germ cell tumors. Phase II trial of a combination of etoposide, ifosfamide and high-dose cisplatin].. PubMed. 19(27). 1263–6.1 indexed citations
Jp, Droz, Mario Ghosn, C Théodore, et al.. (1989). Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumors.. PubMed. 303. 739–47.3 indexed citations
12.
Rougier, Philippe, et al.. (1989). [Efficacy of chemotherapy and combined chemo-radiotherapy in gastric adenocarcinoma].. PubMed. 76(9). 1007–20.
13.
Jp, Droz, C Théodore, Marwan Ghosn, et al.. (1988). Twelve-year experience with chemotherapy in adult metastatic renal cell carcinoma at the Institut Gustave-Roussy.. PubMed. 4(2). 97–9.14 indexed citations
14.
Jp, Droz, et al.. (1987). Phase II trial of ifosfamide/mesna in metastatic adult renal carcinoma.. PubMed. 71(11). 1103–1103.4 indexed citations
15.
Théodore, C, et al.. (1985). [Adjuvant chemotherapy of infiltrating bladder cancer. A feasibility trial].. PubMed. 91(7). 435–40.3 indexed citations
16.
Vitaux, Jean, et al.. (1981). Hématome sous-capsulaire de la rate après pancréatite chronique. Apport diagnostique de l'échotomographie. Deux observations.. La Nouvelle presse médicale. 10(7).2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.